🇺🇸 FDA
Patent

US 10953083

Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts

granted A61KA61K2039/5254A61K2039/55

Quick answer

US patent 10953083 (Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K2039/5254, A61K2039/55, A61K39/12, A61P